A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
about
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@ast
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@en
type
label
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@ast
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@en
prefLabel
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@ast
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@en
P2093
P2860
P1433
P1476
A Novel Biomarker Panel Examin ...... IC Clinical Trials Group PA.3.
@en
P2093
Daniel T Chang
Dongsheng Tu
Gregory Heestand
Jonathan Pai
Kendall Ng
Madeline G Hellendag
Malcolm J Moore
Wayland Chiu
Wendy R Parulekar
P2860
P304
P356
10.1371/JOURNAL.PONE.0147995
P407
P577
2016-01-25T00:00:00Z